Item Details

Title: Resistance of advanced cassava breeding clones to infection by major viruses
in Uganda

Date Published: 2018
Author/s: Daniel Rogers Mukiibi, Titus Alicai, Robert Kawuki, Geoffrey Okao-Okuja, Fred Tairo, Peter Sseruwagi, Joseph Ndunguru, Elijah Miinda Ateka
Data publication:
Funding Agency : Mikocheni Agricultural Research Institute
Copyright/patents/trade marks: The Authors
Journal Publisher: Elsevier Ltd
Affiliation: a Jomo Kenyatta University of Agriculture and Technology, P.O. Box 62000-00200, Nairobi, Kenya
b National Crops Resources Research Institute, P.O. Box 7084, Kampala, Uganda
c
Mikocheni Agricultural Research Institute, P.O. Box 6226, Dar es Salaam, Tanzania
Keywords: Cassava brown streak disease
Cassava mosaic disease
Tolerance
Incidence
Severity
Virus load

Abstract:

Cassava brown streak disease (CBSD) and cassava mosaic disease (CMD) are two viral diseases that cause severe
yield losses in cassava of up to 100%, thereby persistently threatening food and income security in sub-Saharan
Africa. For effective management of these diseases, there is a critical need to develop and deploy varieties with
dual resistance to CBSD and CMD. In this study, we determined the response of advanced breeding lines to field
infection by cassava brown streak viruses (CBSVs) and cassava mosaic begomoviruses (CMBs). This aim helped
in identifying superior clones for downstream breeding. In total, 220 cassava clones, three in uniform yield trials
(UYTs) and 217 in a crossing block trial (CBT), were evaluated for virus and disease resistance. Field data were
collected on disease incidence and severity. To detect and quantify CBSVs, 448 and 128 leaf samples from CBSD
symptomatic and symptomless plants were analyzed by reverse transcription PCR and real-time quantitative
PCR, respectively. In addition, 93 leaf samples from CMD symptomatic plants in the CBT were analyzed by
conventional PCR using CMB species-specific primers. In the CBT, 124 (57%) cassava clones did not express CMD
symptoms. Of the affected plants, 44 (55%) had single African cassava mosaic virus infection. Single Cassava
brown streak virus (CBSV) infections were more prevalent (81.6%) in CBT clones than single Ugandan cassava
brown streak virus (UCBSV) infection (3.2%). Of the three advanced clones in the UYT, NAROCASS 1 and
NAROCASS 2 had significantly lower (P < 0.05) CBSD severity, incidence, and CBSV load than MH04/0300. In
the UYT, only 22% of samples tested had CBSVs, and all showed a negative result for CMBs. The low disease
incidence, severity, and viral load associated with NAROCASS 1 and NAROCASS 2 is evidence of their tolerance
to both CBSD and CMD. Therefore, these two cassava clones should be utilized in CBSD and CMD management in
Uganda, including their utilization as progenitors in further virus resistance breeding.